共 18 条
[1]
[Anonymous], 1990, AM J HOSP PHARM, V47, P1033
[2]
SAFETY OF HANDLING CYTO-TOXIC AGENTS - A CAUSE FOR CONCERN BY PHARMACEUTICAL COMPANIES
[J].
BRITISH MEDICAL JOURNAL,
1985, 291 (6505)
:1318-1319
COLLS, BM
.
[3]
ERIKSEN IL, 1982, PHARM INT, V3, P264
[4]
HARRIS J, 1985, PHARM J, V235, P289
[5]
HITCHINGS CR, 1983, PHARM J, V230, P230
[6]
IGNOFFO R, 1983, APPL THER, P899
[7]
PHARMACY IMPLICATIONS OF THE REVISED OSHA HAZARD COMMUNICATION STANDARD
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1989, 46 (05)
:990-991
MYERS, CE
.
[8]
OAKLEY RA, 1984, PHARM J, V232, P739
[9]
WAKSVIK H, 1981, CANCER TREAT REP, V65, P607
[10]
YODAIKEN S, 1986, OCCUPATIONAL SAFETY, V811